your badges 52W Range $3–$15 35% of range Analyst Rating BUY 12 analysts Price Target $36 +424% upside P/E -1.3 ROE · Net Profit Margin ·

ARTV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $6.83
Market Cap (MRQ) $333M
P/E -1.3
EPS $-3.43
Revenue $0
52W Range $3–$15

ARTV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$0
2023-12-31 → 2025-12-31
EPS$-3.43
2023-12-31 → 2025-12-31
Free Cash Flow·
2024-12-31 → 2024-12-31
Net margin·
2024-12-31 → 2024-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ARTV 5Y avg Peer Median Verdict
P/E -1.3 · · ·
P/B (MRQ) 1.0 · 2.2 Undervalued
Price / FCF (TTM) -4.3 · · ·
Price / Cash Flow (TTM) -4.4 · · ·
Price / Tangible Book 0.9 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -1.7%
Next Report Nov 10, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 27, 2026 $-0.63 $-0.64 1.2%
March 31, 2026 May 7, 2026 $-0.95 $-0.89 -6.8%
Dec. 31, 2025 $-0.85 $-0.84 -0.84%
Sept. 30, 2025 $-0.88 $-0.89 0.83%
June 30, 2025 $-0.87 $-0.82 -5.7%
March 31, 2025 $-0.83 $-0.72 -14.5%
Dec. 31, 2024 $-0.66 $-0.77 14.3%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 14
Metric Trend 202520242023
Revenue $0$251.0K$33M
R&D Expense $70M$50M$50M
SG&A Expense $20M$17M$14M
Operating Expenses $90M$68M$64M
Operating Income $-90M$-67M$-31M
Other Non-op $-14.0K$157.0K$195.0K
Pretax Income ·$-65M$-29M
Income Tax $0$0$72.0K
Net Income $-84M$-65M$-29M
EPS (Basic) $-3.43$-5.81$-35.78
EPS (Diluted) $-3.43$-5.81$-35.78
Shares (Basic) 24,444,05711,258,851802,747
Shares (Diluted) 24,444,05711,258,851802,747
EBITDA ·$-65M·
Balance Sheet 22
Metric Trend 202520242023
Cash & Equivalents $27M$40M$54M
Short-term Investments $81M$145M$23M
Receivables ·$0$1M
Prepaid Expense $5M$3M$1M
Current Assets $113M$189M$80M
PP&E (Net) $7M$6M$8M
PP&E (Gross) $15M$12M$12M
Accum. Depreciation $8M$6M$4M
Other Non-current Assets $458.0K$267.0K$392.0K
Total Assets $131M$210M$105M
Accounts Payable $355.0K$1M$614.0K
Accrued Liabilities $10M$7M$8M
Current Liabilities $13M$12M$12M
Capital Leases $8M$11M$13M
Other Non-current Liabilities ·$73.0K$73.0K
Total Liabilities $21M$23M$51M
Common Stock $3.0K$3.0K·
Retained Earnings $-331M$-247M$-181M
AOCI $103.0K$-129.0K$308.0K
Stockholders' Equity $110M$187M$-162M
Liabilities + Equity $131M$210M$105M
Shares Outstanding 24,595,55024,291,607809,758
Cash Flow 11
Metric Trend 202520242023
D&A $3M$2M$2M
Stock-based Comp $7M$7M$7M
Other Non-cash ·$930.0K·
Operating Cash Flow $-77M$-55M$-47M
CapEx $3M$642.0K$3M
Investing Cash Flow $63M$-120M$-26M
Stock Issued $0$167M·
Net Stock Activity ·$167M·
Financing Cash Flow $9.0K$162M$24M
Net Change in Cash $-13M$-13M$-49M
Free Cash Flow ·$-56M·
Profitability 7
Metric Trend 202520242023
Operating Margin ·-26805.6%·
Net Margin ·-26045.0%·
Pretax Margin ·-26045.0%·
EBITDA Margin ·-25837.0%·
ROA ·-41.5%·
ROE ·-33.7%·
ROIC ·-36.0%·
Liquidity & Solvency 2
Metric Trend 202520242023
Current Ratio ·15.4·
Quick Ratio ·15.1·
Efficiency 2
Metric Trend 202520242023
Asset Turnover ·0.0·
Receivables Turnover ·0.5·
Per Share 5
Metric Trend 202520242023
Book Value / Share ·$7.68·
Revenue / Share ·$0.02·
Cash Flow / Share ·$-4.89·
Cash / Share ·$1.66·
EPS (TTM) $-3.43$-5.81·
Growth Rates 1
Metric Trend 202520242023
Revenue YoY ·-99.2%·
Valuation (TTM) 10
Metric Trend 202520242023
Revenue TTM $0$251.0K·
Net Income TTM $-84M$-65M·
Market Cap ·$245M·
P/E -1.3-1.7·
P/S ·975.5·
P/B ·1.3·
P / Tangible Book 0.91.3·
P / Cash Flow ·-4.4·
P / FCF ·-4.4·
Earnings Yield -80.0%-57.6%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-31
Revenue $0 $251.0K $33M
Operating Margin % · -26805.6% ·
Net Income $-84M $-65M $-29M
Diluted EPS $-3.43 $-5.81 $-35.78

Institutional owners (13F) 73 filers · $392.5M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 73
Value held $392.5M
New positions 39
Exited positions 7
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
39 (+27 vs prior Q) 7 (+2 vs prior Q) 25 (+22 vs prior Q) 2 (-10 vs prior Q) +23.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
RA CAPITAL MANAGEMENT, L.P. $174,169,727 17,955,642 44.38% Shares
VIKING GLOBAL INVESTORS LP $25,260,410 2,604,166 6.44% Shares
Blackstone Inc. $23,313,339 2,403,437 5.94% Shares
5AM Venture Management, LLC $22,827,049 2,353,304 5.82% Shares
Venrock Adviser, LLC $19,822,881 2,043,596 5.05% Shares
FRANKLIN RESOURCES INC $19,373,063 1,997,223 4.94% Shares
Caligan Partners LP $16,840,277 1,736,111 4.29% Shares
VANGUARD CAPITAL MANAGEMENT LLC $9,523,606 981,815 2.43% Shares
SAMSARA BIOCAPITAL, LLC $9,262,152 954,861 2.36% Shares
Blue Owl Capital Holdings LP $8,483,057 874,542 2.16% Shares
Propel Bio Management, LLC $6,755,429 696,436 1.72% Shares
BlackRock, Inc. $6,738,842 694,726 1.72% Shares
CITADEL ADVISORS LLC $5,910,947 609,376 1.51% Shares
SILVERARC CAPITAL MANAGEMENT, LLC $5,092,500 525,000 1.30% Shares
GEODE CAPITAL MANAGEMENT, LLC $3,433,947 353,845 0.87% Shares
BOOTHBAY FUND MANAGEMENT, LLC $3,049,438 314,375 0.78% Shares
Nantahala Capital Management, LLC $2,910,000 300,000 0.74% Shares
Revelation Capital Management, LLC $2,903,317 299,311 0.74% Shares
Alyeska Investment Group, L.P. $2,654,066 273,615 0.68% Shares
ACUTA CAPITAL PARTNERS, LLC $2,526,035 260,416 0.64% Shares
KVP Capital Advisors, LP $1,940,000 200,000 0.49% Shares
WELLINGTON MANAGEMENT GROUP LLP $1,882,848 194,108 0.48% Shares
UBS Group AG $1,784,994 184,020 0.45% Shares
SEVEN GRAND MANAGERS, LLC $1,697,500 175,000 0.43% Shares
STATE STREET CORP $1,607,911 165,764 0.41% Shares
RENAISSANCE TECHNOLOGIES LLC $1,464,700 151,000 0.37% Shares
VANGUARD FIDUCIARY TRUST CO $1,439,412 148,393 0.37% Shares
ADAR1 Capital Management, LLC $1,150,653 118,624 0.29% Shares
VANGUARD GROUP INC $1,055,366 246,006 0.27% Shares
Simplify Asset Management Inc. $983,144 101,355 0.25% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $824,500 85,000 0.21% Shares
TWO SIGMA INVESTMENTS, LP $762,178 78,575 0.19% Shares
NORTHERN TRUST CORP $741,303 76,423 0.19% Shares
DAFNA Capital Management LLC $650,880 67,101 0.17% Shares
Quadrature Capital Ltd $478,647 49,345 0.12% Shares
DIMENSIONAL FUND ADVISORS LP $434,705 44,815 0.11% Shares
XTX Topco Ltd $412,337 42,509 0.11% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $301,796 31,113 0.08% Shares
Velan Capital Investment Management LP $242,500 25,000 0.06% Shares
Atom Investors LP $221,684 22,854 0.06% Shares
BAILARD, INC. $200,790 20,700 0.05% Shares
Spark Investment Management LLC $160,050 16,500 0.04% Shares
GOLDMAN SACHS GROUP INC $153,066 15,780 0.04% Shares
Squarepoint Ops LLC $144,094 14,855 0.04% Shares
ALLIANCEBERNSTEIN L.P. $135,606 13,980 0.03% Shares
Vanguard Global Advisers, LLC $116,187 11,978 0.03% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $115,391 11,896 0.03% Shares
NEW YORK STATE COMMON RETIREMENT FUND $59,170 6,100 0.02% Shares
Russell Investments Group, Ltd. $56,852 5,861 0.01% Shares
WELLS FARGO & COMPANY/MN $53,156 5,480 0.01% Shares

Show all 73 institutional owners →

Activists & 5%+ owners 3 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 filings July 23, 2026 37.90% Amendment · SEC
GC Corp, GC Cell Corporation, Yong-Jun Huh May 28, 2026 12.30% Amendment · SEC
GC Corp., GC Cell Corporation, Yong-Jun Huh July 29, 2024 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 17 insiders · 9 officers · 8 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Fred Aslan Chief Executive Officer Sept. 15, 2026 A 1,604,765 0 6 $-1,384,500
Thad Allen Huston Chief Financial Officer March 10, 2026 A 220,000 0 0 $0
Neha Krishnamohan Chief Financial Officer Nov. 15, 2025 F 99,356 0 0 $0
Gines Diego Miralles President & Head of R&D Sept. 9, 2026 A 122,500 0 0 $0
Jennifer Bush COO, CLO, Compliance Officer Sept. 9, 2026 A 374,529 0 2 $-172,842
Subhashis Banerjee Chief Medical Officer Sept. 9, 2026 A 170,947 0 4 $-179,573
Christopher Horan Chief Tech Operations Officer Sept. 9, 2026 A 323,084 0 2 $-178,773
Heather Raymon SVP, Research and Development May 19, 2026 S 148,228 0 1 $-27,886
Thorsten Graef Chief Medical Officer Feb. 26, 2025 A 80,000 0 0 $0
Daniel G. Baker Director Sept. 10, 2026 A · 0 0 $0
Laura Stoppel Director Sept. 10, 2026 A · 0 0 $0
Elaine K. Sorg Director Sept. 10, 2026 A · 0 0 $0
Alison Moore Director Sept. 10, 2026 A · 0 0 $0
Brian Daniels Director Sept. 10, 2026 A · 0 0 $0
HOUGEN ELIZABETH L Director Sept. 10, 2026 A · 0 0 $0
Yong-Jun Huh Director July 22, 2024 C 1,260,512 0 0 $0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner July 22, 2024 C 194,108 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 12 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.01% 15,680 SH Sept. 11, 2026 Daily
IWM · iShares Trust 0.00% 138,068 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.00% 2,230 NS July 31, 2026 N-PORT
IWO · iShares Trust 0.00% 13,050 SH Sept. 11, 2026 Daily
DCOR · Dimensional ETF Trust 0.00% 3,029 NS July 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.00% 5,863 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 269,149 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 699,899 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.00% 26,837 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.00% 2,934 SH Aug. 19, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.00% 1,342 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 35,940 SH Sept. 11, 2026 Daily

ARTV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 12 analysts BUY
Median target $40.00 +485.7%
4 33.3% Strong Buy
7 58.3% Buy
1 8.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

5 analysts · 2026-09-29

Mean target $35.80 +424.2%

← Below all targets Current price $6.83
Low$23.00 Mean$35.80 High$41.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ARTV · -1.3 -99.2% · · ·
FENC $263M -22.6 -6.1% -21.8% -69.6% ·
CYPH $97M 16.6 · · 6.1% ·
SRZN · · · · · ·
ZNTL $93M -0.7 · · -49.5% ·
OCGN $422M -5.6 8.8% -1537.4% 1488.8% ·
BNTC $460M -13.7 · · -25.0% ·
INDP $6M -0.1 · · -2820.8% ·
SCTX · · · · · ·
EBS $644M 13.3 -28.8% 7.1% 9.9% ·
BBOT $1.00B -2.9 · · -146.2% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026